
这个市场不值得进入,原因很明确:已进入价格竞争区,利润被压在中低位,且新品成功主要靠少数差异化单品支撑,不是一个适合跟风通用款的市场。 现有样本里没有看到你要求的那种30+新品牌涌入的彻底过热信号,但“通用款难赚、差异化才活”的特征已经非常清楚。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这个市场可进入,但只适合有明确差异化的新品,不适合跟风通用款;小商家能做,前提是做出功能和外观差异,靠低价硬拼不行。 从现有样本看,市场并没有出现你要求的“30~100+ 新品牌涌入”那种彻底过热信号,但利润已经被压到中低区间,说明这是一个竞争明确、但仍留有窗口的市场。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,原因很直接:新品里能赚钱的只有少数,整体盈利率只有50%,而且真正跑出来的新品靠的不是低价,而是明显差异化和品牌力;同类通用款已经被挤压成低利润甚至亏损。对小品牌来说,这不是一个自然赢面的市场,除非你能做出明显功能升级和更强的品牌包装,否则不建议推进。
这个市场不值得进入。核心原因很直接:新品利润率只在12.24%~19.52%,大部分还卡在10%~20%的低位,属于明显的价格战区;同时最近只看到2个新品牌/旧品牌新上新样本里,新品牌HOMENURSE靠1个产品赚钱,老品牌Carex的新上新反而亏损,说明这里不是“谁都能靠铺货赚钱”的市场,而是需要更强品牌力和更高投入才可能站住。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0GRBLL1BV | HOMENURSE | 2026-05-13 | Yes | $63.73 | 400pcs | $25492.0 | 19.55% | $4983.69 |
![]() | B00354B818 | Carex | 2023-09-20 | Yes | $34.49 | 1000pcs | $34490.0 | 10.92% | $3766.31 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0GRBLL1BV | HOMENURSE | 2026-05-13 | Yes | $63.73 | 400pcs | $25492.0 | 19.55% | $4983.69 |
这个市场不值得进入,当前已经是明显的高风险价格战市场。 现有样本里只有2个可判定新品,盈利/亏损各1个,整体新品成功率50%,看起来不差,但真正能代表“可复制机会”的只有一条:新品牌 HOMENURSE 的 B0GRBLL1BV;而老牌 Carex 的新推出 B0GSVCSK9X 直接失败,说明旧品牌优势并没有把新品成功率拉起来,市场不是靠品牌数量在扩张,而是靠少数差异化强、预算更重的单品在硬撑。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
结论很直接:这个市场不值得进入,已经进入价格竞争区,且对新品牌并不友好。 现有数据只看到2个新品牌样本,成功率50%,但这是被极小样本误导的;真正能代表新品牌的只有HOMENURSE一条成功案例,Carex一条失败案例,市场信号更像是“少量高差异化产品能活,其余通用款很难赚”。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |